{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:22:27Z","timestamp":1792516947037,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072621"],"award-info":[{"award-number":["82072621"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203705"],"award-info":[{"award-number":["82203705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["LR19C050001"],"award-info":[{"award-number":["LR19C050001"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.canlet.2023.216145","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:12:40Z","timestamp":1680009160000},"page":"216145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients"],"prefix":"10.1016","volume":"562","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-3551","authenticated-orcid":false,"given":"Kailun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiannan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216145_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chinese Med J"},{"key":"10.1016\/j.canlet.2023.216145_bib2","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216145_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216145_bib4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2023.216145_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216145_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clon.2007.11.013","article-title":"Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response","volume":"20","author":"Sanghera","year":"2008","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216145_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib10","doi-asserted-by":"crossref","first-page":"1 e","DOI":"10.1016\/j.ejca.2013.06.048","article-title":"EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum","volume":"50","author":"van de Velde","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216145_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12014-018-9192-2","article-title":"The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature","volume":"15","author":"Chauvin","year":"2018","journal-title":"Clin. Proteonomics"},{"key":"10.1016\/j.canlet.2023.216145_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jprot.2018.02.030","article-title":"Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response","volume":"179","author":"Bowden","year":"2018","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.canlet.2023.216145_bib14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","article-title":"Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial","volume":"32","author":"Fokas","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.2011.39.7901","article-title":"Neoadjuvant treatment response as an early response indicator for patients with rectal cancer","volume":"30","author":"Park","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2023.216145_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216145_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cell.2017.01.014","article-title":"Applications of immunogenomics to cancer","volume":"168","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216145_bib19","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216145_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216145_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2023.216145_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-06-1734","article-title":"CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma","volume":"13","author":"Wahlin","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216145_bib23","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216145_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216145_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109408","article-title":"Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases","volume":"64","author":"Birnhuber","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2023.216145_bib26","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1172\/JCI125366","article-title":"Fra-2\u2013expressing macrophages promote lung fibrosis","volume":"129","author":"Ucero","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216145_bib27","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.0803577","article-title":"Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2","volume":"183","author":"Lawson","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2023.216145_bib28","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216145_bib29","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"Eferl","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216145_bib30","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1093\/nar\/gkac256","article-title":"A systematic comparison of FOSL1, FOSL2 and BATF-mediated transcriptional regulation during early human Th17 differentiation","volume":"50","author":"Shetty","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216145_bib31","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.celrep.2018.04.038","article-title":"Long-term persistence of exhausted CD8 T cells in chronic infection is regulated by MicroRNA-155","volume":"23","author":"Stelekati","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2023.216145_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm.3807","article-title":"Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216145_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/acs.jproteome.0c00381","article-title":"PulseDIA: data-independent acquisition mass spectrometry using multi-injection pulsed gas-phase fractionation","volume":"20","author":"Cai","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2023.216145_bib34","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41596-022-00727-1","article-title":"High-throughput proteomic sample preparation using pressure cycling technology","volume":"17","author":"Cai","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2023.216145_bib35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th edition: colorectal cancer","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib36","first-page":"104","article-title":"DPHL: a DIA pan-human protein mass spectrometry library for robust biomarker discovery","volume":"18","author":"Zhu","year":"2020","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.canlet.2023.216145_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/bioinformatics\/btaa1088","article-title":"ProteomeExpert: a docker image based web-server for exploring, modeling, visualizing, and mining quantitative proteomic data sets","volume":"37","author":"Zhu","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2023.216145_bib38","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216145_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216145_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.radonc.2018.06.022","article-title":"Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer","volume":"128","author":"Jia","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib41","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","article-title":"Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis","volume":"19","author":"Zorcolo","year":"2012","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib42","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12885-019-5724-z","article-title":"High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer","volume":"19","author":"Abrahamsson","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2023.216145_bib44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/gut.2009.196626","article-title":"Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer","volume":"59","author":"Tweedle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2023.216145_bib45","doi-asserted-by":"crossref","first-page":"23836","DOI":"10.18632\/aging.104037","article-title":"Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression","volume":"12","author":"Xu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.canlet.2023.216145_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13046-020-01576-0","article-title":"Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1","volume":"39","author":"Song","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216145_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexcr.2018.08.016","article-title":"Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer","volume":"373","author":"Li","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2023.216145_bib48","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216145_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216145_bib50","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216145_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6998","article-title":"The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation","volume":"6","author":"Han","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.canlet.2023.216145_bib52","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1038\/s41467-019-11906-2","article-title":"Tumor-reprogrammed resident T cells resist radiation to control tumors","volume":"10","author":"Arina","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216145_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9013","article-title":"cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216145_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:08:42Z","timestamp":1759594122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":54,"alternative-id":["S0304383523000964"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216145","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216145"}}